louisiana glp-1 gi obstruction class action semaglutide louisiana bowel obstruction class action Louisiana Diabetes Drugs & Gastrointestinal Injuries louisiana glp-1 gi obstruction lawsuit

About 1 in 8 adults are now taking a GLP-1 drug for obesity, disease, or both, up 6 percentage points from May 2024, according to KFF poll results released in November

Your philosophy should be the backbone of every benefits decision you make and should be communicated to your teams so they can understand and appreciate the decisions made on their behalf

discovered that exendin-4 enhances arteriovenous fistula function in rats with CKD by upregulating eNOS/HO-1

Boards need to be thinking about this before they sign the deal, not after

By scavenging free radicals and bolstering other antioxidant enzymes, glutathione aids the body in defending against damage caused by environmental stressors, promoting healthy and radiant skin